These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 81309)

  • 21. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H; Luo Y; Haruta Y; Seon BK
    Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic determinants common to established human B-cell lines, but not shared by human T-cell lines (molt and sommer).
    Takada Y; Takada A; Minowada J
    Clin Exp Immunol; 1975 Aug; 21(2):267-77. PubMed ID: 52426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of human leukemia by membrane antigen analysis with xenoantisera.
    Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
    Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
    Minowada J; Tsubota T; Greaves MF; Walters TR
    J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reaction of various human normal and leukemic cells and cells of different cell lines with rabbit antisera prepared against membrane fraction of B and T cell lines.
    Koubek K
    Neoplasma; 1983; 30(2):187-95. PubMed ID: 6188960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
    Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
    Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.
    Poláková K; Chorváth B; Sedlák J; Duraj J; Matoska J; Karpatová M
    Neoplasma; 1985; 32(6):641-8. PubMed ID: 3911080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line.
    Pesando JM; Hoffman P; Abed M
    J Immunol; 1986 Dec; 137(11):3689-95. PubMed ID: 3491146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T; Barcos MP; Seon BK
    Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic and immunoglobulin markers of human leukemic B-cell lines.
    Minowada J; Oshimura M; Tsubota T; Higby DJ; Sandberg AA
    Cancer Res; 1977 Sep; 37(9):3096-9. PubMed ID: 406986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome abnormalities in leukemia and lymphoma.
    Rowley JD
    Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16).
    Kohno S; Minowada J; Sandberg AA
    J Natl Cancer Inst; 1980 Mar; 64(3):485-93. PubMed ID: 6928235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia.
    Lazarus H; Barell EF; Krishan A; Livingston DM; Harris K; Schlossman SF; Chess L
    Cancer Res; 1978 May; 38(5):1362-7. PubMed ID: 205365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of xenoantiserum produced against B cell acute lymphoblastic leukemia cell line.
    Akagi T; Sonobe H; Miyoshi I; Yoshimoto S
    Acta Med Okayama; 1982 Oct; 36(5):325-30. PubMed ID: 6184955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.